27662-1-AP

antibody from Proteintech Group

Targeting: DPYD DPD

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

27662-1-AP

Provider

Proteintech Group

Product name

DPYD antibody

Antibody type

Polyclonal

Description

DPYD antibody (Cat. #27662-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human, Mouse, Rat and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Pyrimidine metabolism reshapes immune microenvironment and implies poor prognosis in glioma.

Huang R, Yang J, Li X, Chen H, Liu X
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025 May;27(5):2127-2142

---

Differential expression of capecitabine-related metabolic enzymes in hepatocellular carcinoma and its clinical value: a retrospective cohort study.

Lu J, Yin Z, Zhuang Y, Wang Z, Zheng H, Cao L, Kong D, Duan J, Chen S, Chen T
Discover oncology 2025 Jun 12;16(1):1066

---

Integrating network pharmacology and experimental validation to uncover the synergistic effects of Huangqi ()-Ezhu () with 5-fluorouracil in colorectal cancer models.

Xiying T, Ruxin GU, Jing T, Yu Z, RuiQian S, Gang Y, Shuo Z, Decai T
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 2025 Apr;45(2):385-398

---

Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma.

Li Y, Li F, Xu L, Shi X, Xue H, Liu J, Bai S, Wu Y, Yang Z, Xue F, Xia Y, Dong H, Shen F, Wang K
Theranostics 2024;14(9):3526-3547

---

Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy.

Zhang J, Sun R, Lyu Y, Liu C, Liu Y, Feng Y, Fu M, Wong PJC, Du Z, Qiu T, Zhang Y, Zhuang D, Qin Z, Yao Y, Zhu W, Guo T, Hua W, Yang H, Mao Y
Nature communications 2024 Nov 19;15(1):10005

---

CIAO1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic Fe-S enzymes.

Maio N, Orbach R, Zaharieva IT, Töpf A, Donkervoort S, Munot P, Mueller J, Willis T, Verma S, Peric S, Krishnakumar D, Sudhakar S, Foley AR, Silverstein S, Douglas G, Pais L, DiTroia S, Grunseich C, Hu Y, Sewry C, Sarkozy A, Straub V, Muntoni F, Rouault TA, Bönnemann CG
The Journal of clinical investigation 2024 Jun 17;134(12)

---

Pathway-based stratification of gliomas uncovers four subtypes with different TME characteristics and prognosis.

Huang R, Han B, Zhang Y, Yang J, Wang K, Liu X, Wang Z
Journal of cellular and molecular medicine 2024 Apr;28(8):e18208

---

Exploration and Validation of Pancreatic Cancer Hub Genes Based on Weighted Gene Co-Expression Network Analysis and Immune Infiltration Score Analysis.

Li XX, Li H, Jin LQ, Tan YB
Pharmacogenomics and personalized medicine 2023;16:467-480